A study looking at online reporting of side effects at home after cancer treatment (ePRIME)

Cancer type:

Ovarian cancer
Vaginal cancer
Vulval cancer
Womb (uterine or endometrial) cancer

Status:

Open

Phase:

Other

This study is for women with a gynaecological cancer who have finished treatment. And who are going to one of the following hospitals:

  • St James’ University Hospital Bexley wing
  • Bradford Teaching Hospitals NHS Foundation Trust
  • Calderdale & Huddersfield NHS Foundation Trust
  • Airedale NHS Foundation Trust

Gynaecological cancers include:

More about this trial

There is a ‘Before’ and ‘After’ part to this study. This summary is about the ‘Before’ part. 

ePRIME is a web based system for patients to report symptoms while they are at home. The researchers want to find out how well it works compared with the standard care patients get when they are going to the hospital frequently. 

This study is for women after they have had treatment for a gynaecological cancer. Before the ePRIME system is tested, the researchers need to know about the symptoms and experiences of patients who have the usual follow up care after treatment. 

This means that the team will ask women who have completed treatment for a gynaecological cancer to fill in a questionnaire. The answers will tell them about:

  • how the services currently run
  • the relationship between patient and doctors, and or nurses
  • the patients’ experiences 
  • patients’ quality of life Open a glossary item during follow up

Who can enter

The following bullet points list the entry conditions for this study. Talk to your doctor running the study if you are unsure about any of these. They will be able to advise you. 

You may be able to join this study if you are a woman who is going to one of the following hospitals:

  • St James’ University Hospital Bexley Wing 
  • Bradford Teaching Hospitals NHS Foundation Trust 
  • Calderdale and Huddersfield NHS Foundation Trust
  • Airedale NHS Foundation Trust

You have one of the following cancers:

And all of the following must appy:

  • Your cancer was stage 2 to 4
  • You have finished treatment 
  • There is no sign of cancer on examination or tests (it is in remission) or they show the cancer has reduced (a partial remission)
  • You are able to read and understand English
  • You have access to the internet
  • You are at least 16 years old

You cannot join this study if you have a mental health condition or problems with your mental capacity such as a learning disability.

Trial design

There are 2 parts to this study. 

Part 1 (Before Study)
This part of the study looks at what is the usual care for women who have had treatment for a gynaecological cancer. The team need 84 women to join this stage. 

You fill in a questionnaire when you join the study then at:

  • 6 months
  • 12 months

The questions ask about your general health, how you are feeling and any side effects you might have. 

At the end of these 12 months, the team might ask you to take part in an interview about your experience of follow up after treatment. 

When the team have completed this stage they will open part 2, the ‘After Study’. This part will test the online system and compare it with the results of part 1.

Hospital visits

The interviews are arranged at a time and place convenient to you. 

Side effects

There are no side effects if you take part in this study.

Location

Airedale
Bradford
Calderdale
Leeds

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Galina Velikova

Supported by

Leeds Teaching Hospitals NHS Trust 
Yorkshire Cancer Research
University of Leeds

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

14613

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Around 1 in 5 people take part in clinical trials

3 phases of trials

Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think